Osteoarthritis biomarker responses and cartilage adaptation to exercise: A review of animal and human models.


Journal

Scandinavian journal of medicine & science in sports
ISSN: 1600-0838
Titre abrégé: Scand J Med Sci Sports
Pays: Denmark
ID NLM: 9111504

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 24 12 2018
revised: 29 03 2019
accepted: 04 04 2019
pubmed: 30 4 2019
medline: 2 10 2019
entrez: 30 4 2019
Statut: ppublish

Résumé

Regular physical activity has been suggested as having both preventive and therapeutic benefits for individuals with osteoarthritis (OA). However, evidence of whether exercise and which type of exercise constitutes a benefit or a risk in the development and progression of OA remains debatable. This may be due to the evaluation of the effect of physical activity or new disease-modifying OA drugs which is currently based on radiographic criteria (eg, joint space width) and the lack of correlation with clinical signs and symptoms (eg, pain and loss of function). Moreover, OA typically manifests itself as changes within the joint space and subchondral bone as well as the whole joint structure, including progressive degradation of cartilage, menisci, ligaments, and synovial inflammation. Biomarkers are being developed to quantify joint remodeling and disease progression notably involving the articular cartilage and synovial fluid. The primary purpose of this review was to evaluate the current literature and to provide further insight based on OA biomarkers and the role physical activity plays in the management of OA. Osteoarthritis biomarkers together with radiographic imaging evidence will ideally guide healthcare providers to incorporate exercise recommendations into clinical management and offer patients evidence-based and individually tailored exercise prescriptions.

Identifiants

pubmed: 31033061
doi: 10.1111/sms.13435
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1072-1082

Informations de copyright

© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Auteurs

Marija Mazor (M)

University of Orléans, Orléans, France.

Thomas M Best (TM)

Division of Sports Medicine, Department of Orthopedics, Health Sports Medicine Institute, University of Miami, Coral Gables, Florida.

Annabelle Cesaro (A)

University of Orléans, Orléans, France.

Eric Lespessailles (E)

University of Orléans, Orléans, France.
Service de Rhumatologie, Centre Hospitalier Régional d'Orléans, La Source, France.

Hechmi Toumi (H)

University of Orléans, Orléans, France.
Service de Rhumatologie, Centre Hospitalier Régional d'Orléans, La Source, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH